Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Rheumatology|July 17, 2015
Nuclear Factor-κB-inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort StudyKaren I Maijer, Ae Ri Noort, Maria J H de Hair, et al.
Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma modelsMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Proteomics. Clinical Applications|June 26, 2015
A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritisEmily S Collins, Aisha Q Butt, David S Gibson, et al.
Arthritis and Rheumatism|January 1, 2009
Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patientsJoost W van der Heijden, Ruud Oerlemans, Ben A C Dijkmans, et al.
Arthritis and Rheumatism|August 29, 2013
Local synovial engagement of angiogenic TIE-2 is associated with the development of persistent erosive rheumatoid arthritis in patients with early arthritisMarleen G H van de Sande, Daphne de Launay, Maria J H de Hair, et al.
RMD Open|October 18, 2024
The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI studyGiulia Frazzei, Sophie H M Cramer, Robert B M Landewé, et al.
Immunology Letters|July 13, 2010
Human T-cell memory consists mainly of unexpanded clonesPaul L Klarenbeek, Paul P Tak, Barbera D C van Schaik, et al.
Arthritis and Rheumatism|October 18, 2002
Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritisMaarten C Kraan, Arno W R van Kuijk, Huibert J Dinant, et al.
Arthritis and Rheumatism|December 16, 2011
Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritisSarah Krausz, Maria J H Boumans, Danielle M Gerlag, et al.
Pageof 31